Lavo Life Sciences is a United States-based startup founded in 2022, specializing in AI-accelerated quantum chemistry for rapid drug development. Their software simulates drug behavior at the atomic scale, providing a valuable resource for pharmaceutical companies to expedite drug development. In December 2023, the company secured Pre Seed Round investment from BBQ Capital. Lavo Life Sciences operates in the AI, Biotechnology, and Pharmaceutical industries, positioning itself at the intersection of cutting-edge technology and life-saving innovations. This investment reflects the growing interest in leveraging advanced AI technologies for breakthroughs in drug discovery and development.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Pre Seed Round | Unknown | 1 |
|
15 Dec 2023 |
| Pre Seed Round | $500.00K | 2 |
|
05 Apr 2023 |
No recent news or press coverage available for Lavo Life Sciences.
We care about your data, and we'd love to use cookies make your experience better.
